Dr Dinesh VG, General Practitioner in Singapore

About Dr Dinesh VG

Dr Dinesh VG is a medical doctor with an undying passion for Clinical Research and strives towards improving the quality and accessibility of healthcare. Currently, Dr Dinesh is engaged in a Collaborative Ocular Tuberculosis Study (COTS) initiative as the head of the Steering Committee, which is aimed at addressing Ocular Tuberculosis with Cloud computing, Big Data, and Machine Learning.

Prior to this, Dr Dinesh also served as a Practicing Clinician and Researcher at several medical institutions in Singapore that includes, Singapore General Hospital (SGH), Tan Tock Seng Hospital (TTSH), Khoo Teck Puat Hospital (KTPH), Singapore National Eye Center (SNEC) and National Healthcare Group Eye Institute (NHGEI).

As an avid clinical researcher, Dr Dinesh has a keen interest in scientific research relating to Ophthalmology, Infectious Disease, Public Health, and Medical Technology. He also frequently presents findings from his medical research or big data at various professional conferences like the ARVO 2014 (Orlando, USA), IOIS 2015 (San Francisco, USA), ARVO 2016 (Seattle, USA), Fairness Accountability and Transparency in Artificial Intelligence 2017 (NUS Computing, SG), and many others.

Education

MBBS

Awards and Achievements

Tan Tock Seng Hospital International Ophthalmology Congress 1st Place (Open Category) Award
Tan Tock Seng Hospital International Conference Sponsorship Award, 2014
Wong Hock Boon Research Symposium Distinction Award (Open Category), 2014
Ministry of Health Holdings Clinical Research Scholarship Award, 2015
Ministry of Health Holdings Clinical Research Scholarship Award, 2016
Forbes 30 under 30 (Healthcare and Science), 2018
International Ophthalmology Congress Best Paper Award (1st Runner Up), 2018
Singhealth DUKE-NUS Congress 2018 Best Paper Award (Education), 2018
Commonwealth Fellow (Innovation), 2018

Recent Answers

View All

Singapore Healthcare

What difficulties may overseas Singaporean medical students face when returning back to Singapore for work?

Hi there! Small disclaimer before I take a stab at this question: I am a local grad from YLL. Although I had clerkships in India, UK and US, and studied for over a year in Australia when I was younger, I am not an international medical grad (IMG). That being said, I was asked my thoughts on this and so am commenting based on my perspectives as well as experiences working with fellow IMG colleagues. My colleague has already nicely summarised the 2 main points (1 and 2) here that come to mind personally.

Read full answer

Answered By

Dr Dinesh VG

General Practitioner

Get Quote

Publications

Hui Koh S, Ponampalam R, Han Lim S, Visva Gunasekeran D. Cutaneous Exposure to Cobra Venom: An Uncommon Presentation. Wilderness & Environmental Medicine. 2015;26(2):267-269. doi:10.1016/j.wem.2014.10.007
Bansal S, Gunasekeran DV, Ang B, et al. Controversies in the pathophysiology and management of hyphema. Survey of Ophthalmology. 2016;61(3):297-308. doi:10.1016/j.survophthal.2015.11.005
Ocular manifestations of tuberculosis: an update. Expert Review of Ophthalmology. Published 2016. Accessed May 27, 2019.
Iyer JV, Agrawal R, Yeo TK, et al. Aqueous humor immune factors and cytomegalovirus (CMV) levels in CMV retinitis through treatment – The CRIGSS study. Cytokine. 2016;84:56-62. doi:10.1016/j.cyto.2016.05.009
Kee AR, Gonzalez-Lopez JJ, Al-Hity A, et al. Anti-tubercular therapy for intraocular tuberculosis: A systematic review and meta-analysis. Survey of Ophthalmology. 2016;61(5):628-653. doi:10.1016/j.survophthal.2016.03.001
Gunasekeran DV, Agrawal R. Algorithm for Work-Up of Episcleritis and Scleritis. The Uveitis Atlas. 2016:1-5. doi:10.1007/978-81-322-2506-5_106-1
Agrawal R, Gunasekeran DV. Diffuse Anterior Scleritis. The Uveitis Atlas. 2016:1-3. doi:10.1007/978-81-322-2506-5_107-1
Agrawal R, Gunasekeran DV, Gonzalez-Lopez JJ, et al. PERIPHERAL RETINAL VASCULITIS. Retina. 2017;37(1):112-117. doi:10.1097/iae.0000000000001239
Visual Morbidity and Ocular Complications in Presumed Intraocular Tuberculosis: An Analysis of 354 Cases from a Non-Endemic Population. Ocular Immunology and Inflammation. Published 2018. Accessed May 27, 2019.
Chia KJW, Gunasekeran DV, Laude A. The Impact of Switching Anti-Vascular Endothelial Growth Factor Therapy in the Management of Exudative Age-Related Macular Degeneration. Ophthalmic surgery, lasers & imaging retina. 2017;48(10):859-869. doi:10.3928/23258160-20170928-14
Agrawal R, Gunasekeran DV, Grant R, et al. Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)–1. JAMA Ophthalmology. 2017;135(12):1318. doi:10.1001/jamaophthalmol.2017.4485
Agrawal R, Grant R, Gupta B, et al. What does IGRA testing add to the diagnosis of ocular tuberculosis? A Bayesian latent class analysis. BMC Ophthalmology. 2017;17(1). doi:10.1186/s12886-017-0597-x
Gunasekeran DV. Technology and chronic disease management. The Lancet Diabetes & Endocrinology. 2018;6(2):91. doi:10.1016/s2213-8587(17)30441-2
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Description of the Spectrum of Choroidal Involvement in 245 Patients with Tubercular Uveitis. Ocular Immunology and Inflammation. Published 2018. Accessed May 27, 2019.
Agrawal R, Gunasekeran DV, Raje D, et al. Global Variations and Challenges With Tubercular Uveitis in the Collaborative Ocular Tuberculosis Study. Investigative Opthalmology & Visual Science. 2018;59(10):4162. doi:10.1167/iovs.18-24102